Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)WithdrawnNCT01826864What this trial is testingSargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II MelanomaWho this might be right forStage IB MelanomaStage IIA MelanomaStage IIB Melanoma+1 more Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00698100What this trial is testingVaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA VaccinesWho this might be right forMelanomaSkin Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT03541148What this trial is testingEvaluation of Oncoxin-Viusid® in Cutaneous MelanomaWho this might be right forCutaneous Melanoma, Stage IIMalignant Cutaneous MelanomaCutaneous Melanoma, Stage III Catalysis SL 20
Testing effectiveness (Phase 2)Ended earlyNCT05234437What this trial is testingA Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c MelanomaWho this might be right forMelanoma QBiotics Group Limited 1
Large-scale testing (Phase 3)Study completedNCT01989572What this trial is testingSargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By SurgeryWho this might be right forIris MelanomaMedium/Large Size Posterior Uveal MelanomaMucosal Melanoma+17 more National Cancer Institute (NCI) 815
Testing effectiveness (Phase 2)Study completedNCT00089063What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+6 more National Cancer Institute (NCI) 40
Not applicableStudy completedNCT03028948What this trial is testingInteractive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With MelanomaWho this might be right forStage 0 Skin MelanomaStage I Skin MelanomaStage IA Skin Melanoma+9 more Rutgers, The State University of New Jersey 485
Not applicableStudy completedNCT00897442What this trial is testingCollecting Tumor Samples From Patients With Gynecological TumorsWho this might be right forBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more Gynecologic Oncology Group 275
Very early researchStudy completedNCT01425749What this trial is testingStudy to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCIWho this might be right forMelanoma Craig L Slingluff, Jr 25
Early research (Phase 1)Study completedNCT01989559What this trial is testingBooster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By SurgeryWho this might be right forRecurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00104845What this trial is testingVaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaWho this might be right forMelanoma (Skin) Memorial Sloan Kettering Cancer Center 19
Very early researchStudy completedNCT01748747What this trial is testingVaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By SurgeryWho this might be right forRecurrent MelanomaStage IIA MelanomaStage IIB Melanoma+5 more Mayo Clinic 30
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Looking for participantsNCT04697576What this trial is testingIntralesional Influenza Vaccine for the Treatment of Stage I-IV MelanomaWho this might be right forClinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8Clinical Stage IB Cutaneous Melanoma AJCC v8+6 more Carlo Contreras 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04309409What this trial is testingAdjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk MelanomaWho this might be right forMalignant Melanoma Stage II University Hospital, Essen 374
Testing effectiveness (Phase 2)UnknownNCT05013099What this trial is testingStudy of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic MalignanciesWho this might be right forMelanomaMerkel Cell Carcinoma, UnspecifiedRenal Cell Carcinoma+1 more ImaginAb, Inc. 70
Large-scale testing (Phase 3)WithdrawnNCT01861938What this trial is testingModified Melanoma Vaccine for High Risk or Low Residual Disease PatientsWho this might be right forHigh Risk HLA-A2+ MelanomaMetastatic Disease Hadassah Medical Organization
Early research (Phase 1)Active Not RecruitingNCT06551064What this trial is testingAssessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma PatientsWho this might be right forMelanoma, Stage IIMelanoma Stage III Formycon AG 96
Testing effectiveness (Phase 2)Study completedNCT02126579What this trial is testingPhase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR AgonistsWho this might be right forMelanomaMetastatic MelanomaMucosal Melanoma Craig L Slingluff, Jr 50